US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ホーム
投資
株式
アメリカ
USOTC
Icade SA (PK) (CDMGF) 銘柄情報

Icade SA (PK) (CDMGF)

22.75

0.00

(0.00%)

終了 6月12日 5:00AM

Icade SA (PK) (CDMGF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

22.75

( - )

買値

22.74

売値

25.67

出来高

-

0.00 日の範囲 0.00

22.64 52 週間の範囲 26.44

時価総額

前日終値

22.75

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 111,847

発行済株式数

75,826,079

配当利回り

1.92 (9.50%)

PER

-12.86

1 株当たり利益 (EPS)

-1.62

歳入

1.34B

純利益

-123M

Icade is a real estate player that strives to make cities more pleasant places to live for everyone. Icade combines expertise in property investment (portfolio worth 6.1bn euros as of 12/31/2025 100% + Group share of joint ventures) and property development (2025 economic revenue of 1.1bn pounds), s... Icade is a real estate player that strives to make cities more pleasant places to live for everyone. Icade combines expertise in property investment (portfolio worth 6.1bn euros as of 12/31/2025 100% + Group share of joint ventures) and property development (2025 economic revenue of 1.1bn pounds), supporting clients, elected officials and partners throughout France in building the city of tomorrow. A city more respectful of nature and more aligned with the way we live, work and travel. Icade is listed as an on Euronext Paris, with the Caisse des Depots group as its leading shareholder. Icade was incorporated in 1954, France. 詳細を表示

セクター

Real Estate

業界

Reits

ウェブサイト

www.icade.fr

本社

Puteaux, France

設立

2026

Icade SA (PK) is listed in the Real Estate sector of the その他OTC with ticker CDMGF. The last closing price for Icade (PK) was US$22.75. Over the last year, Icade (PK) shares have traded in a share price range of US$ 22.64 to US$ 26.44.

Icade (PK) currently has 75,826,079 shares in issue. The market capitalisation of Icade (PK) is US$1.73 billion. Icade (PK) has a price to earnings ratio (PE ratio) of -12.86.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	-2.125	-8.54271356784	24.875	24.875	22.75	250	22.75	CS
26	-1.05	-4.41176470588	23.8	25.54	22.75	130	23.45234758	CS
52	-3.41	-13.0351681957	26.16	26.44	22.64	182	24.15846393	CS
156	-14.95	-39.6551724138	37.7	38.92	21.061	448	28.65540947	CS
260	-69.2977	-75.2845535521	92.0477	92.0477	21.061	506	40.12288357	CS

CDMGF - Frequently Asked Questions (FAQ)

What is the current Icade SA (PK) share price?

The current share price of Icade SA (PK) is US$ 22.75

How many Icade SA (PK) shares are in issue?

Icade SA (PK) has 75,826,079 shares in issue

What is the market cap of Icade SA (PK)?

The market capitalisation of Icade SA (PK) is USD 1.73B

What is the 1 year trading range for Icade SA (PK) share price?

Icade SA (PK) has traded in the range of US$ 22.64 to US$ 26.44 during the past year

What is the PE ratio of Icade SA (PK)?

The price to earnings ratio of Icade SA (PK) is -12.86

What is the cash to sales ratio of Icade SA (PK)?

The cash to sales ratio of Icade SA (PK) is 1.18

What is the registered address of Icade SA (PK)?

The registered address for Icade SA (PK) is Tour Hyfive, Puteaux, Ile-de-France, 92800

What is the Icade SA (PK) website address?

The website address for Icade SA (PK) is www.icade.fr

Which industry sector does Icade SA (PK) operate in?

Icade SA (PK) operates in the REITs sector

CA Market News

CA Market News 5分前

Vertical Data and Quantum eMotion Partner to Bring Quantum Cybersecurity to AI Infrastructure DeploymentsJune 12, 2026 3:00 AM
ACCESS NewswireInitial Pilot Deployment Targeted for 2026 Across Vertical Data's GPU Cluster and Edge Data Center Pipeline

US Market News

US Market News 5分前

AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year ResultsJune 12, 2026 3:00 AM
PR Newswire (US) class="legen

US Market News

US Market News 5分前

AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year ResultsJune 12, 2026 3:00 AM
PR Newswire (US) class="legen

sharkey1

sharkey1 18分前

So we wait a year, or Accord scores the patent and Elite gets Tentative approval
then things might change .

iHub News

iHub News 20分前

SpaceX Secures $75 Billion Ahead of Historic Market DebutJune 12, 2026 2:45 AM
IH Market News SpaceX (NASDAQ:

sharkey1

sharkey1 27分前

THX, very confusing,
google says
None of these products have yet been approved by the FDA, and Elite therefore does not yet market any products. Elite Labs also engages in contract research ...Read more

no harm no foul
If they went to trial now, it would probly t

Libertas

Libertas 28分前

Thanks for sharing that, too bad most will write it off as nonsense.

🐻

IH Admin [Shelly]

IH Admin [Shelly] 29分前

Looks like your computer tried to login you in with your gmail account and it accidentally created a new alias.

Nightdaytrader

Nightdaytrader 31分前

Split T, next Friday is federal holiday and I believe markets are closed.

Nd9

God Bless America

God Bless America 46分前

Here I am. From 44 in 2008 to 62 now. So frustrated !

Split T

Split T 46分前

Just a friendly reminder that next Fiday June 19th is Quadruple. Witching Day, IMVHO we are going to see some crazy trading next week and due to the latest news I'm thinking we will be over $15.30 at close next Friday with volume in excess of 8 million shares according to my William Allen Getty.

God Bless America

God Bless America 53分前

No IPO for FNMA, FMCC. Just relist and do Second Public Offering.

God Bless America

God Bless America 56分前

No IPO for FNMA, FMCC. Just relist and do Second Public Offering

Tom turtles

Tom turtles 1時間前

US Market News

US Market News 1時間前

Caledonia Mining Corporation Plc: Utilisation of the Block Admission in Respect of ATM Sales AgreementJune 12, 2026 2:00 AM
ACCESS Newswire(NYSE American:CMCL)(AIM:CMCL)(VFEX:CMCL)SAINT HELIER, JE /

CA Market News

CA Market News 1時間前

Exercise of OptionsJune 12, 2026 2:00 AM
ACCESS NewswireTORONTO, ON / ACCESS Newswire / June 12, 2026 / Sintana Energy Inc. (TSXV:SEI)(AIM:SEI)(OTCQX:SEUSF) ("Sintana" o

US Market News

US Market News 1時間前

Caledonia Mining Corporation Plc: Director/PDMR Shareholding NotificationJune 12, 2026 2:05 AM
ACCESS Newswire(NYSE American:CMCL)(AIM:CMCL)(VFEX:CMCL)SAINT HELIER, JE / ACCES

Tom turtles

Tom turtles 1時間前

$1.62 after hours.....ya baby

space~farm

space~farm 1時間前

I can only imagine the deficiencies in their submission. This will be caught up in a never ending RFI.

jxyzobrien

jxyzobrien 1時間前

criminals run the country
so nothing will be done
lots of boot lickers

jxyzobrien

jxyzobrien 1時間前

bull market till qe dies
new fed chair will have some say next week
till change is clear its qe as usual.

rx7171

rx7171 2時間前

Negativity is primarily the funk we feel that we see extremely positive data that needs a longer and larger trial to get approval, delaying the approval for a minimum of three years.

Whether Anavex will even exist by then or be bought out is the unknown.

An investor’s b

JohnnyRotton

JohnnyRotton 2時間前

Most are stuck, this state allows unlimited shares if I remember right. They can dilute forever. Only a few will ever get out without a rs or buy back. They are making enough cash to do either if they choose. The stock cant achieve true value via rs because market cap is 1/10th actual value now. Tou

skitahoe

skitahoe 2時間前

During the past 5 or so years our market cap has shrunk from nearly $1 billion to the $307 million it is today. Dilution is less than doubled, yet the market cap is under about a third of what it was. The point is, LP has added much extra values, FlaskWorks, Advent, Roswell, etc. to what the compa

Triton Minerals

Worthington Steel

ASN Groenprojectenfonds

0.95% 19oct2028 0.95% 19...

Vecima Networks

First Watch Restaurant

iShares US Regional Banks

1.98000 27/05/32 1.98000...

Exchange Traded Funds

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。